Oncolytics Biotech, Inc. (ONCY)

1.175 +0.18 (+18.61%) USD  |  NASDAQ  |  Jan 21, 11:37
More

Oncolytics Biotech Change in Receivables (TTM)

Change in Receivables (TTM) Chart

View Change in Receivables (TTM) for ONCY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (TTM) Range, Past 5 Years

View Change in Receivables (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (TTM) Benchmarks

View Change in Receivables (TTM) Benchmarks
Start Trial
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
Xenon Pharmaceuticals, Inc. Upgrade
ProMIS Neurosciences, Inc. --